title: Serotonin stimulates megakaryocytopoiesis via the 5-HT2 receptor.
abstract: It is known that platelet alpha-granule constituents including platelet-derived growth factor (PDGF), platelet factor 4 (PF4) and transforming growth factor-beta (TGF-beta) can affect megakaryocytopoiesis. Serotonin, a platelet dense granule constituent has been shown to have a mitogenic effect on fibroblasts and smooth muscle cells but whether it has the same effect on megakaryocytes remains unclear. In this study, we investigated the effect of serotonin on megakaryocytopoiesis and the possible mechanism of its effect using the mouse plasma clot culture method. The results show that: (a) serotonin significantly stimulates megakaryocyte colony formation with maximum stimulation at 100 nM; (b) enhanced action is found between serotonin and interleukin-3 (IL-3), interleukin-6 (IL-6), granulocyte macrophage-colony stimulating factor (GM-CSF), erythropoietin (EPO) and PDGF; (c) ketanserin, a 5-HT2 receptor antagonist, blocks the mitogenic effect of serotonin on megakaryocytopoiesis; and (d) Meg-01 cells (a megakaryocyte cell line) express 5-HT2 receptors. This study demonstrates that serotonin has a mitogenic effect on megakaryocytopoiesis and this effect may be mediated via the 5-HT2 receptor which is known to be coupled to G protein. It is suggested that serotonin may also be involved in the feedback control of megakaryocytopoiesis.
authors: Centre for Thrombosis and Vascular Research, School of Pathology, University of New South Wales, Sydney, Australia.
authors: M
authors: M
authors: Yang
authors: A
authors: A
authors: Srikiatkhachorn
authors: M
authors: M
authors: Anthony
authors: B H
authors: BH
authors: Chong
mesh_terms: D000818:Animals; D001792:Blood Platelets / Q000166:cytology*; D002460:Cell Line; D004921:Erythropoietin / Q000494:pharmacology; D005260:Female; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000494:pharmacology; D006410:Hematopoiesis / Q000187:drug effects*; D007377:Interleukin-3 / Q000494:pharmacology; D015850:Interleukin-6 / Q000494:pharmacology; D007650:Ketanserin / Q000494:pharmacology; D008533:Megakaryocytes / Q000187:drug effects*; D051379:Mice; D008807:Mice, Inbred BALB C; D010982:Platelet-Derived Growth Factor / Q000494:pharmacology; D011985:Receptors, Serotonin / Q000378:metabolism*; D012701:Serotonin / Q000494:pharmacology*; D012702:Serotonin Antagonists / Q000494:pharmacology; D013134:Spiperone / Q000378:metabolism / Q000494:pharmacology; D013917:Thrombin / Q000494:pharmacology
chemical_list: D007377:Interleukin-3; D015850:Interleukin-6; D010982:Platelet-Derived Growth Factor; D011985:Receptors, Serotonin; D012702:Serotonin Antagonists; D004921:Erythropoietin; D012701:Serotonin; D013134:Spiperone; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; D007650:Ketanserin; D013917:Thrombin